Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of PF-04449913 for the Treatment of Acute Myeloid Leukemia Patients With High Risk of Post-Allogeneic Stem Cell Transplantation Relapse

NCT01841333 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT01841333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01841333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of PF-04449913 for the Treatment of Acute Myeloid Leukemia Patients With High Risk of Post-Allogeneic Stem Cell Transplantation Relapse
Lead sponsor
University of Colorado, Denver
Phase
Phase 2
Overall status
Completed
Start date
April 29, 2013
Completion date
February 4, 2020
Enrollment
31 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adult acute myeloid leukemia in remission, recurrent adult acute myeloid leukemia